The U.S. Department of Justice announced on October 30, 2026 that the DEA is moving forward with the first batch of federal registrations for state-licensed medical marijuana dispensaries. It's the first phase of Attorney General Todd Blanche's April 23 order, which set up Schedule III controls for certain qualifying medical marijuana activities.
The opening round covers more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia. Each one had to pass a DEA pre-registration investigation, and DOJ is clear that a state license alone does not automatically earn federal registration. Registered shops now fall under federal security, recordkeeping, and inventory-control rules.
“The American people deserve access to the best medical treatments in the world,” Blanche said, adding that DOJ will keep prosecuting illegal marijuana trafficking.
More is coming in phases: DEA is still processing dispensary applications and reviewing manufacturers and distributors, which need extra steps like facility inspections. Businesses that applied in the initial 60-day window and are still pending may keep transacting under the order's terms.
Two big caveats: the order does not authorize recreational marijuana, and marijuana outside its scope stays Schedule I. Broader rescheduling is a separate federal proceeding.
What it means for travelers: Adult-use rules don't change, and state medical programs still decide who can shop, so check before you go.






